Sneha Kollenchery Ramanathan

Sneha Kollenchery Ramanathan

Auto-generated profile, based on publicly available information

Sneha Kollenchery Ramanathan

Laboratory of Molecular Materials Division of Biophysics and Bioengineering Department of Physics, Chemistry and Biology Linköping University Linköping 581 83 Sweden

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
RSRozalin Shamasha
Rozalin Shamasha
SRSneha Kollenchery Ramanathan
Sneha Kollenchery Ramanathan
KOKristin Oskarsdotter
Kristin Oskarsdotter
FBFatemeh Rasti Boroojeni
Fatemeh Rasti Boroojeni
AZAleksandra Zielińska
Aleksandra Zielińska
JJJohan Junker
Johan Junker
Chronic wounds and severe skin injuries pose significant clinical challenges, as existing treatments like cultured epidermal autografts and tissue engineering strategies fail to regenerate functional dermal tissue effectively. These methods often result in scarring due to poor tissue integration, low cell density, and limited extracellular matrix (ECM) production. Conventional skin tissue engineering relies on time‐intensive cell expansion, producing constructs that lack the complexity of native dermal structures. Here, a bioprintable biphasic granular hydrogel bioink (µInk) based on cell‐laden porous gelatin microcarriers (PGMs) is presented, enabling fabrication of ultra‐high cell density constructs that promote ECM production for dermal regeneration in vitro and in vivo. Primary human dermal fibroblasts are cultured and expanded on PGMs in a bioreactor prior µInk formulation. The cell‐laden PGMs are cross‐linked via copper‐free click chemistry, creating a shear‐thinning granular bioink. The µInk is 3D bioprinted into structurally stable constructs with high cell viability. In vivo, the bioprinted constructs supported neovascularization, hydrogel remodeling, and tissue integration over 28 days. Cells maintained their tissue‐specific phenotype, proliferated, and produced dermal ECM post‐transplantation. The µInk offers a promising approach to generating high cell‐density constructs for scar‐free wound healing and for advancing complex tissue reconstruction.